Charity Navigator has awarded Dana-Farber Cancer Institute a four-star rating
April 12, 2010
For the ninth consecutive year, Charity Navigator has awarded Dana-Farber Cancer Institute a four-star rating, its highest ranking. The designation, according to Charity Navigator, "differentiates Dana-Farber from its peers and demonstrates to the public it is worthy of their trust."
Charity Navigator evaluates the financial health of more than 5,500 of the largest not-for-profit organizations in the United States. This includes reviewing organizational efficiency (program expenses, administrative expenses, fundraising expenses, and fundraising efficiency) and organizational capacity (how well it has sustained its programs and services over time, and whether it can continue to do so, even if it loses support or faces broad economic downturns).
"Less than one percent of the charities we rate have received at least nine consecutive four-star evaluations, indicating that Dana-Farber Cancer Institute consistently executes its mission in a fiscally responsible way, and outperforms most charities in America," said Ken Berger, president and CEO of Charity Navigator.
"We are blessed with broad public support for our efforts against cancer, and we recognize our great responsibility to use our resources as wisely as possible," said Edward J. Benz, Jr., MD, president of Dana-Farber. "Donors to Dana-Farber and the Jimmy Fund can feel confident that their gifts are important and effective investments in lifesaving cancer research and new therapies."
Dana-Farber Cancer Institute is one of the country's leading cancer care and research institutions in the United States. More than 45,000 adult and pediatric cancer patients came to Dana-Farber in 2009 for treatment or evaluation.
To learn more about how to support Dana-Farber's care and research programs, visit the Make a Gift page.
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.